Date posted 6 July 2020
Round 2 applications close 11 November 2020
Round 3 applications close 10 March 2021
The Medical Research Future Fund (MRFF) Coronavirus Research Response- 2020 COVID-19 Vaccine Candidate Research Grant Opportunity will accelerate the development of promising COVID-19 prophylactic vaccine candidates for which research and development is already underway. The prophylactic vaccine must be intended to induce active long-term immunity against COVID-19.
The intended outcome of the research is to support rapid development of a safe and effective COVID-19 prophylactic (disease-preventing) vaccine, which induces active long-term immunity, within the next 12-18 months.
The vaccine candidate must have progressed beyond early or “developmental” stage research to pre-clinical or clinical investigation, and applicants must have already generated proof-of-concept data that supports pre-clinical or clinical development of the vaccine candidate. Applicants must also demonstrate access to critical resources necessary to complete the project in the stipulated timeframes.
The grant opportunity will provide up to $13.65 million, with a maximum grant size of $3 million. All projects must be completed before or by 30 June 2023.
This grant opportunity is being administered by NHMRC on behalf of the Commonwealth Department of Health. This opportunity is supported by the Medical Research Future Fund (MRFF).
Further information on the Medical Research Future Fund is available on the Department’s website at: https://www.health.gov.au/mrff.
Key dates
Expressions of Interest open
15 June 2020
Closing dates for Expressions of Interest are:
- Round 1 closing date: 15 July 2020
- Round 2 closing date: 11 November 2020
- Round 3 closing date: 10 March 2021
